ENVISION: A Phase 3 Randomized, Double-blind, Placebo-Controlled Multicenter Study with an Open-label Extension to Evaluate the Efficacy and Safety of Givosiran in Patients with Acute Hepatic Porphyrias

  • Anderson, Karl (PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date3/8/183/31/21

Funding

  • Alnylam Pharmaceuticals, Inc: $13,065.50